23.5% of Ripple (XRP) on-chain trading volume occurred between 1 PM and 4 PM UTC. This concentration falls within the three-hour overlap of business hours in London and New York, marking an increase from 14.3% a year ago in 2025. This time frame coincides with the early U.S. market and late European market, serving as a reference point for domestic investors to gauge when Ripple liquidity thickens. Evernote interprets this trend as an increase in trading during 'banking hours,' aligning with growing institutional interest. However, the public ledger does not identify trading entities, making it difficult to conclude that this figure indicates institutional buying or price direction. Evernote explained that this concentration during the time frame is evident across order books, automated market makers (AMM), and cross-currency payments. Evernote plans to launch as a financial company in October 2025 to assist institutions in utilizing Ripple, which includes plans for a NASDAQ listing and raising over $1 billion in funding. Further data is needed to assess the impact of Ripple's time-based trading concentration on demand or price.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.














Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.
